VDR Gene Polymorphisms are Overrepresented in German Patients with Type 1 Diabetes Compared to Healthy Controls without Effect on Biochemical Parameters of Bone Metabolism

W. J. Fassbender; B. Goertz; K. Weismüller; B. Steinhauer; H. Stracke; D. Auch; T. Linn; R. G. Bretzel

doi:10.1055/s-2002-33262

Hormone and Metabolic Research, Table of Contents

Horm Metab Res 2002; 34(6): 330-337
DOI: 10.1055/s-2002-33262

Original Clinical

VDR Gene Polymorphisms are Overrepresented in German Patients with Type 1 Diabetes Compared to Healthy Controls without Effect on Biochemical Parameters of Bone Metabolism

W. J. Fassbender ¹ , B. Goertz ² , K. Weismüller ² , B. Steinhauer ² , H. Stracke ² , D. Auch ³ , T. Linn ³ , R. G. Bretzel ³

¹Medical Dept. I, Johann-Wolfgang-Goethe-University, Frankfurt, Germany
²Institute of Pathology, Justus-Liebig-University, Giessen, Germany
³Institute of Clinical Chemistry and Pathobiochemistry, Justus-Liebig-University, Giessen, Germany

W. J. Fassbender and B. Goertz contributed equally to this manuscript.

Abstract

Type 1 diabetic individuals are known to develop disorders of bone metabolism resulting in osteopenia. Previous studies have suggested an influence of vitamin D receptor alleles on bone metabolism and susceptibility for type 1 diabetes mellitus. The present study was initiated to investigate the distribution of vitamin D receptor alleles in Caucasian type 1 diabetic patients and their relation to bone turnover parameters.

75 patients were included and compared to 57 healthy controls. Three vitamin D receptor alleles were examined (BsmI, TaqI and FokI); serum levels of intact osteocalcin, parathyroid hormone, bone specific alkaline phosphatase, the carboxy terminal extension peptide of type I procollagen, 25-OH-vitamin D levels, HbA1c and urinary deoxypyridinoline excretion were measured.

We observed a higher frequency of the TT genotype in diabetic patients, but no difference in markers of bone turnover between diabetics and non-diabetics in either sex. Bone turnover was different in men and in women without any association with vitamin D receptor genotype. No association was found between diabetes duration, age of onset or metabolic control and bone turnover parameters.

In summary, our results show an association between the TT genotype and diabetes in Germans, but no difference in bone turnover markers between diabetics and non-diabetics.

Key words

Bone Metabolism - Genetics - Osteopenia - Hormone Receptor - Autoimmune

Full Text

References

1 Lampeter E F, Signore A, Gale E A, Pozzilli P. Lessons from the NOD mouse for the pathogenesis and immunotherapy of human type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1989; 32 703-708
2 Gamble D R. The epidemiology of insulin dependent diabetes, with particular reference to the relationship of virus infection to its aetiology. Epidemiol Rev. 1980; 2 49-70
3 Christau B, Kromann H, Andersen O O. et al . Incidence, seasonal and geographical patterns of juvenile-onset insulin-dependent diabetes mellitus in Denmark. Diabetologia. 1977; 13 281-284
4 Hitman G A, Tarn A C, Winter R M. et al . Type 1 (insulin dependent) diabetes and a highly variable locus close to the insulin gene on chromosome 11. Diabetologia. 1985; 28 218-222
5 Bell G I, Horta S, Karam J H. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes. 1984; 33 176-183
6 Cordell H J, Todd J A. Multifactorial inheritance in type 1 diabetes. Trends Genet. 1995; 11 499-503
7 McDermott M F, Ramachandran A, Ogunkolade B W. et al . Allelic variation in the vitamin D receptor influences susceptibility of IDDM in Indian Asians. Diabetologia. 1997; 40 971-975
8 Chang T J, Lei H H, Yeh J I. et al . Vitamin receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population. Clinical Endocrinology. 2000; 52 575-580
9 Mathieu C, Laureys J, Sobis H, Vandeputte M, Waer M, Bouillon R. 1,25-dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes. 1992; 41 1491-1495
10 The EURODIAB Substudy 2 Study Group .Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. Diabetologia 1999 42: 51-54
11 Kayath M J, Dib S A, Vieira J GH. Prevalence and magnitude of osteopenia associated with insulin-dependent diabetes mellitus. J Diabetes Complications. 1994; 8 97-104
12 Kelly P J, Hopper J L, Macaskill G T. et al . Genetic factors in bone turnover. J Clin Endocrinol Metab. 1991; 72 808-813
13 Issa L L, Leong G M, Eisman J A. Molecular mechanism of vitamin D receptor action. Inflamm Res. 1998; 47 451-475
14 Morrison N A, Qi J C, Tokita A. et al . Prediction of bone density from vitamin D receptor alleles. Nature (London). 1994; 367 284-287
15 Hauache O M, Lazaretti-Castro M, Andreoni S. et al . Vitamin D receptor gene polymorphism: Correlation with bone mineral density in a Brazilian population with insulin-dependent diabetes mellitus. Osteoporos Int. 1998; 8 204-210
16 Alberti K GMM, Zimmet P Z. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Provisional Report of a WHO Consultation. Diabet Med. 1998; 15 539-553
17 Garnero P, Delmas P D. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab. 1993; 77 1046-1053
18 Garnero P, Grimaux M, Seguin P, Delmas P D. Characterisation of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Miner Res. 1994; 9 255-264
19 Melkko J, Niemi S, Risteli L. et al . Radioimmunoassay of the carboxy terminal propeptide of human type I procollagen. Clin Chem. 1990; 36 1328-1332
20 Haddad J G, Chyu K J. Competitive protein-binding radioimmunoassay for 25-hydroxycholecalciferol. J Clin Endocrinol Metab. 1971; 33 992-995
21 Kao P C, Jiang N-S, Klee G G. et al . Development and validation of a New Radioimmunoassay for Parathyrin (PTH). Clin Chem. 1982; 28 69-74
22 Seibel M J, Cosman V, Shen V, Ratcliffe A, Lindsay R. Urinary hydroxy-pyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. J Bone Min Res. 1993; 8 881-889
23 Carling T, Ridefelt P, Hellmann P, Rastadt J, Akerström G. Vitamin D Receptor Polymorphism Correlate to Parathyroid Cell Function in Primary Hyperparathyroidism. J Clin Endocrinol Metab. 1997; 82 1772-1775
24 Gross C, Krishnan A V, Malloy P J, Eccleshall T R, Zhao X Y, Feldman D. The Vitamin D Receptor Gene Start Codon Polymorphism: A Functional Analysis of FokI Variants. J Bone Miner Res. 1998; 13 1691-1699
25 Müller K, Brendtzen K. Inhibition of Human T Lymphocyte Proliferation and Cytokine Production by 1,25 Dihydroxyvitamin D₃. Differential effects on CD45RA+ and CD45RO+ cells. Autoimmunity. 1992; 14 37-43
26 Chofflon M, Gonzalez V, Weiner H L, Hafler D A. Inflammatory cerebrospinal fluid T cells have activation requirements characteristic of CD4+CD45RA^- T cells. Eur J Immunol. 1989; 19 1791-1795
27 Cippiteli M, Santoni A. Vitamin D3: a transcriptional modulator of the interferon-gamma gene. Eur J immunol. 1998; 28 3017-3030
28 Tsoukas C D, Provvedini D M, Manolagas S C. 1,25-Dihydroxyvitamin D3: A Novel Immunomodulatory Hormone. Science. 1984; 224 1438-1440
29 Reichel H, Koepffler H P, Tobler A, Norman A. 1α,25-Dihydroxyvitamin D₃ inhibits γ-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci USA. 1987; 84 3385-3389
30 D’Ambrosio D, Cippitelli M, Cocciolo M G. et al . Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. J Clin Invest. 1998; 101 252-262
31 Nashold F E, Miller D J, Hayes C E. 1,25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis. J Neuroimmunol. 2000; 103 171-179
32 Fournier C, Gepner P, Sadouk M, Charreire J. In vivo beneficial effects of cyclosporine A and 1,25-dihydroxyvitamin D3 on the induction of experimental autoimmune thyreoiditis. Clin Immunol Immunopathol. 1990; 54 53-63
33 Lemire J M, Ince A, Takashima M. 1,25 Dihydroxyvitamin D₃ attenuates the expression of experimental murine lupus of MRL/I mice. Autoimmunity. 1992; 12 143-148
34 Lemire J M, Archer D. 1,25 Dihydroxyvitamin D₃ prevents the In vivo induction of mourn experimental autoimmune encephalomyelitis. J Clin Invest. 1991; 87 1103-1107
35 Fukazawa T, Yabe I, Kikuchi S, Sasaki H, Hamada T, Miyasaka K, Tashiro K. Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. J Neurol Sci. 1999; 166 47-52
36 Ingles S A, Haile R W, Henderson B E. et al . Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications or association studies. Cancer Epidemiol Biomarkers Prev. 1997; 6 93-98
37 Beelman C A, Parker R. Degradation of mRNA in Eukaryotes. Cell. 1995; 81 179-183
38 Verbeek W, Gombart A F, Shiohara M, Campbell M, Koeffles H P. Vitamin D receptor: no evidence for allele-specific mRNA stability in cells which are heterozygous for the TaqI restriction enzyme polymorphism. Biochem Biophys Res Commun. 1997; 238 77-80
39 Durrin L K, Haile R W, Ingles S A, Coetzee G A. Vitamin D receptor 3’-untranslated region polymorphisms: lack of effect on RNA stability. Biochim Biophys Acta. 1999; 1453 311-320
40 Pani M A, Knapp M, Donner H. et al . Vitamin D Receptor Allele Combinations Influence Genetic Susceptibility to type 1 Diabetes in Germans. Diabetes. 2000; 49 504-507
41 Serjeantson S, Ranford P, Kirk R L. et al . HLA-DR and -DQ DNA genotyping in insulin-dependent diabetes patients in South India. Dis Markers. 1987; 5 101-108
42 Gross C, Eccleshall T R, Malloy P J, Villa M L, Marcus R, Feldman D. The presence of a polymorphism in the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res. 1996; 11 1850-1855
43 Arai H, Miyamoto H I, Taketani Y. A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res. 1997; 12 915-921
44 Jurutka P W, Remus L S, Whitfield G K. et al . The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol. 2000; 14 401-420
45 Yamagata M, Nakajima S, Tokita A. et al . Analysis of the stable levels of messenger mRNA derived from different polymorphic alleles in the vitamin D receptor gene. J Bone Miner Metab. 1999; 17 164-170
46 Bouillon R, Bex M, van Herck E, Laureys J, Doom L, Lesaffre E, Ravussin E. Influence of age, sex and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus. J Clin Endocrinol Metab. 1995; 80 1194-1202
47 Patel S R, Xu Y, Koenig R J. et al . Effect of glucose on the function of the calcitriol receptor and vitamin D metabolism. Kidney Inter. 1997; 52 79-86
48 Inaba M, Terada M, Koyama H. et al . Influence of high glucose on 1,25-Dihydroxyvitamin D₃-induced effect on human osteoblast-like MG-63 cells. J Bone Miner Res. 1995; 10 1050-1056
49 Pedrazzoni M, Ciotti G, Piolo G. et al . Osteocalcin levels in diabetic subjects. Calcif Tissue Int. 1989; 45 331-336
50 Rico H, Hernandez E R, Cabranes J A. et al . Suggestion of a deficient osteoblastic function in diabetes mellitus: The possible cause of osteopenia in diabetics. Calcif Tissue Int. 1989; 45 71-73
51 Pietschmann P, Schernthaner G, Woloszuk W. Serum osteocalcin levels in diabetes mellitus: analysis of the type diabetes and microvascular complications. Diabetologia. 1988; 31 892-895
52 Burkhardt R, Moser W, Bartl R. et al . Is diabetic osteoporosis due to microangiopathy?. Lancet. 1981; 1 844
53 Takeshita N, Yoshino T, Mutoh S. Possible involvement of corticosterone in bone loss of genetically diabetic db/db mice. Horm Metab Res. 2000; 32 147-151
54 Fassbender W J, Steinhauer B, Stracke H, Schumm-Draeger P-M, Usadel K-H. Validation of a new automated immunoassay for measurement of intact osteocalcin. Clin Lab 2002 in press
55 Kemink S A, Hermus A R, Swinkels L M, Luttermann J A, Smals A G. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology. J Endocrinol Invest. 2000; 23 295-303
56 Inukai T, Fujiwara Y, Tayama K, Aso Y, Takemura Y. Alterations in serum levels of 1 alpha, 25(OH)2 D3 and osteocalcin in patients with early diabetic nephropathy. Diabetes Res Clin Pract. 1997; 38 53-59
57 Miazgowski T, Czekalski S. A 2-year follow-up study on bone mineral density and markers of bone turnover in patients with long-standing insulin-dependent diabetes mellitus. Osteoporos Int. 1998; 8 399-403
58 Henry Y. Ethnic and gender differences in bone mineral density and bone turnover in young adults: effect of size. Osteoporosis Int. 2000; 11 512-517
59 Dahl E, Nordal K O, Halse J, Attramadal A. Histomorphometric analysis of normal bone from the iliac crest of Norwegian subjects. Bone and Mineral. 1988; 3 369-377
60 Dawson-Hughes B, Harris S S, Finneran S. Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype. J Bone Miner Res. 1995; 10 S162
61 Fleet J C, Harris S S, Wood R J, Dawson-Hughes B. The BsmI vitamin D receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopausal black and white women. J Bone Miner Res. 1995; 10 985-990
62 Tokita A, Matsumoto H, Morrison N A. et al . Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women. J Bone Miner Res. 1996; 11 1003-1009
63 Krall E A, Parry P, Lichter J B. et al . Vitamin D receptor alleles and rates of bone loss: Influences of years since menopause and calcium intake. J Bone Miner Res. 1995; 10 978-984
64 Houston L A, Grant S F, Reid D M, Ralston S H. Vitamin D receptor polymorphism, bone mineral density, and osteoporotic vertebral fracture. Studies in a UK population. Bone. 1995; 18 249-252
65 Uitterlinden A G, Pols H A, Burger H. et al . A large-scale population-based study of the association of vitamin D receptor gene polymorphisms with bone mineral density. J Bone Miner Res. 1996; 11 1241-1248
66 Looney J E, Yoon H K, Fischer M. et al . Lack of prevalence of the BB vitamin D receptor genotype in severely osteoporotic women. J Clin Endocrinol Metab. 1995; 80 2158-2162
67 Garnero P, Borel O, Sornay-Rendu E, Arlot M E, Delmas P D. Vitamin D Receptor Gene Polymorphisms Are Not Related to Bone Turnover, Rate of Bone Loss, and Bone Mass in Postmenopausal Women: The OFELY Study. J Bone Miner Res. 1996; 11 827-834
68 Morrison N A, Yeoman R, Kelly P J, Eisman J A. Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci USA. 1992; 89 6665-6669

B. Goertz, M.D.

Institute of Pathology

Justus-Liebig-University · Langhansstrasse 10 · 35385 Giessen, Germany

Phone: + 49 (641) 99-41100

Fax: + 49 (641) 99-41109

Email: Birgit.Goertz@patho.med.uni-giessen.de